Literature DB >> 8207016

Reversible inhibition of gene expression by a psoralen functionalized triple helix forming oligonucleotide in intact cells.

G Degols1, J P Clarenc, B Lebleu, J P Léonetti.   

Abstract

Triple helix formation of nucleic acids is the most rational approach to designing site-specific transcription inhibitors. To increase their efficiency, reactive moieties such as psoralen or ethenocytosine have been introduced on the third strand. In transfected cells, these compounds induce a site-specific covalent binding of the third strand to the targeted sequence and efficiently block RNA polymerases. However, the stability of this transcription inhibition has never been checked. We have designed a plasmid containing a triple helix binding site in the coding region of the beta-galactosidase reporter gene and a polymerase chain reaction assay to follow quantitatively the cross-link of a psoralen-derivatized third strand in transfected cells. This assay has revealed that the cross-link was removed within a few hours, leading only to a transitory inhibition of gene expression. Control experiments in DNA repair-deficient cells suggest the implication of repair enzymes in this process.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207016

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Proton NMR studies of 5'-d-(TC)(3) (CT)(3) (AG)(3)-3'--a paperclip triplex: the structural relevance of turns.

Authors:  Laura B Pasternack; Shwu-Bin Lin; Tsung-Mei Chin; Wei-Chen Lin; Dee-Hua Huang; Lou-Sing Kan
Journal:  Biophys J       Date:  2002-06       Impact factor: 4.033

Review 2.  Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities.

Authors:  Taco G Uil; Hidde J Haisma; Marianne G Rots
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

Review 3.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

4.  A molecular anchor for stabilizing triple-helical DNA.

Authors:  K R Fox; P Polucci; T C Jenkins; S Neidle
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

5.  Torsionally-strained DNA and intermolecular purine-purine-pyrimidine triple-helix formation.

Authors:  M Musso; M W Van Dyke
Journal:  Mol Cell Biochem       Date:  1996-01-12       Impact factor: 3.396

6.  Multiple rounds of transcription by RNA polymerase II at covalently cross-linked templates.

Authors:  M N Szentirmay; M Musso; M W Van Dyke; M Sawadogo
Journal:  Nucleic Acids Res       Date:  1998-06-01       Impact factor: 16.971

7.  In vivo persistence of DNA triple helices containing psoralen-conjugated oligodeoxyribonucleotides.

Authors:  M Musso; J C Wang; M W Van Dyke
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

Review 8.  Repair of DNA lesions associated with triplex-forming oligonucleotides.

Authors:  Joanna Y Chin; Peter M Glazer
Journal:  Mol Carcinog       Date:  2009-04       Impact factor: 4.784

9.  Detection of covalent triplex within human cells.

Authors:  A L Guieysse; D Praseuth; M Grigoriev; A Harel-Bellan; C Hélène
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

10.  Transplatin-conjugated triplex-forming oligonucleotides form adducts with both strands of DNA.

Authors:  Meghan A Campbell; Paul S Miller
Journal:  Bioconjug Chem       Date:  2009-12       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.